- Enzyme replacement therapy in patients with mucopolysaccharidoses2016 | First Faculty of Medicine
- Enzyme replacement therapy in lysosomal storage diseases2015 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Enzyme replacement therapy for Gaucher disease in twin pregnancy2009 | First Faculty of Medicine
- Effect of rapid cessation of enzyme replacement therapy: A report of 5 more cases2014 | First Faculty of Medicine
- Enzyme replacement therapy in GSD IIPublication without faculty affiliation
- The pharmacology of multiple regimens of agalsidase alfa enzyme replacement therapy for Fabry disease2007 | Third Faculty of Medicine
- Consensus statement on enzyme replacement therapy for mucopolysaccharidosis IVA in Central and South-Eastern European countries2022 | First Faculty of Medicine
- Long-term uninterrupted enzyme replacement therapy prevents liver disease in murine model of severe homocystinuria2020 | First Faculty of Medicine
- The heart in Fabry disease - from pathogenesis to enzyme replacement therapy2010 | First Faculty of Medicine
- The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts2019 | First Faculty of Medicine
- Enzyme replacement therapy in patients with Gaucher disease in the Czech RepublicPublication without faculty affiliation
- Effectivity of enzyme replacement therapy in Fabry desease. Studies at the cellular levelPublication without faculty affiliation
- Enzyme replacement therapy in patients with Gaucher diseasePublication without faculty affiliation
- Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria2018 | First Faculty of Medicine
- Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data2009 | First Faculty of Medicine
- Fabry disease, an overview and the most common neurological manifestations2018 | First Faculty of Medicine
- Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy was underpowered - Authors' reply2015 | First Faculty of Medicine
- Fabry disease and its cardiac involvement2018 | First Faculty of Medicine
- Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process2009 | First Faculty of Medicine
- Enzyme replacement therapy and renal function in 201 patients with Fabry Disease2006 | First Faculty of Medicine
- Abnormal expression and processing of uromodulin in Fabry disease reflects tubular cell storage alteration and is reversible by enzyme replacement therapy2008 | First Faculty of Medicine
- Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy2009 | Third Faculty of Medicine
- Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction Versus Treatment Switch2014 | Central Library of Charles University
- Enzyme replacement therapy (ERT) in females with Fabry disease: an update from FOS - the Fabry Outcome SurveyPublication without faculty affiliation
- Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapyPublication without faculty affiliation
- Fabry disease +12018 | First Faculty of Medicine
- Early cardiac changes in children with Anderson-Fabry disease2013 | First Faculty of Medicine
- Safety of agalsidase alfa enzyme replacement therapy in a cohort of 1329 patients in FOS - The Fabry Outcome SurveyPublication without faculty affiliation
- Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease2015 | First Faculty of Medicine